Apr 14, 2026
Suzy Jackson, a digital health specialist focusing on Patient Tech, highlights the shift in the pharmaceutical industry from a provider-focused model to direct engagement with patients. Using AI to create a more consumer-like, personalized healthcare experience will benefit patients and inform researchers and providers...
Apr 14, 2026
Suzy Jackson, a digital health specialist focusing on Patient Tech, highlights the shift in the pharmaceutical industry from a provider-focused model to direct engagement with patients. Using AI to create a more consumer-like, personalized healthcare experience will benefit patients and inform researchers and providers...
Apr 13, 2026
Dr. Robert Rifkin, medical oncologist and hematologist at the University of Colorado in Steamboat Springs. He was also a clinical investigator in the trial that led to the approval of BLENREP, a multiple myeloma drug from GSK. Multiple myeloma is the second most common blood cancer, and while the prognosis has...
Apr 13, 2026
Dr. Robert Rifkin, medical oncologist and hematologist at the University of Colorado in Steamboat Springs. He was also a clinical investigator in the trial that led to the approval of BLENREP, a multiple myeloma drug from GSK. Multiple myeloma is the second most common blood cancer, and while the prognosis has...
Apr 9, 2026
Haresh Patel, Founder of Diagnostic MD AI, discusses the transformative potential of AI in healthcare diagnostics, particularly for patients with chronic or complex issues. Based on his own struggle to get an accurate diagnosis of an autoimmune condition, Haresh has developed a patient-centric platform...